Intrinsic Value

The intrinsic value of AtriCure Inc (A5I) under the Base Case is 32.56 EUR per share. Compared with the current market price of 59.5 EUR, the stock appears Overvalued by 45% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

A5I Intrinsic Value
€32.56
Overvaluation 45%
Intrinsic Value
Price €59.5
Monitor A5I
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €26.05
Get notified when the price drops into your buy zone
Current Price €59.5
Intrinsic Value €32.56
Margin of Safety 20% €26.05
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to A5I

Fundamental Analysis

What AtriCure Does

Health Care

AtriCure makes medical devices used by heart surgeons to treat atrial fibrillation and related heart rhythm problems. Its products include surgical ablation tools that create controlled scar lines in the heart tissue, plus systems used to remove or close off the left atrial appendage, a part of the heart linked to stroke risk in some patients. The company sells mainly to hospitals and cardiac surgery teams.

Headquarters
United States of America US
Employees
1 350
IPO date
Aug 5, 2005
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
AtriCure Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

ATRC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one A5I stock?

The intrinsic value for AtriCure Inc (A5I) under the Base Case is 32.56 EUR.

Is A5I stock undervalued or overvalued?

Compared with the current market price of 59.5 EUR, the stock appears Overvalued by 45% .

Back to Top